Skip to content
Home/GPs/Azulis Capital
Azulis Capital

Azulis Capital

Paris, France·azuliscapital.fr
AUM
€495M
Funds
4
vintages 2004–2021
Portfolio
20
Exits
25

Key facts

HQParis, France

Recent exits

Father & Sons
Father & Sons
Consumer2025 · 11yr hold
Ital Express (MMF V)
Ital Express (MMF V)
Industrials2024 · 5yr hold
Meotec
Meotec
TMT2024 · 6yr hold
Radiologie Paris Ouest
Healthcare2024 · 5yr hold

Coverage notes

4 funds tracked, 45 portfolio companies (20 active · 25 realized). Verified weekly from public filings and deal announcements.

Sector breakdown

45 companies
Consumer
14 · 31%
Healthcare
8 · 18%
Industrials
7 · 16%
Construction
5 · 11%
Business Services
5 · 11%
TMT
3 · 7%
Logistics
2 · 4%
MedTech
1 · 2%

Funds & portfolio

Every fund Azulis Capital has raised, with its portfolio companies. Hand-checked from public filings.

4 funds
Azulis MMF VIBuyout
2021 · 5yr€280M12 active

Unrealized

12 held
ACENSI
AcensiActive
TMTFrance· Entry 2025
ADVANS GROUP
Advans GroupActive
IndustrialsFrance· Entry 2023
DestiaActive
HealthcareFrance· Entry 2021
EURADIF
EuradifActive
ConstructionFrance· Entry 2022
IndustrialsFrance· Entry 2021
HealthcareFrance· Entry 2026
ConsumerFrance· Entry 2025
ConsumerFrance· Entry 2021
Business ServicesFrance· Entry 2026
NERCO
NercoActive
ConstructionFrance· Entry 2024
ORSYS
OrsysActive
Business ServicesFrance· Entry 2021
WICHARD
WichardActive
IndustrialsFrance· Entry 2023
Azulis MMF VBuyoutDivesting
2015 · 11yr€215M8 active · 9 realized

Unrealized

8 held
AvidomActive
HealthcareFrance· Entry 2016
Eksae
EksaeActive
TMTFrance· Entry 2019
ConsumerFrance· Entry 2019
GROUPE FRIO
Groupe FrioActive
ConsumerFrance· Entry 2019
Ital Passion
Ital PassionActive
ConsumerFrance· Entry 2019
Jordenen
JordenenActive
Business ServicesFrance· Entry 2018
ConsumerFrance· Entry 2016
Love & GreenActive
ConsumerFrance· Entry 2019

Realized

9 exits
Destia (MMF V)Exited 2021
HealthcareFrance· Entry 2016
Secondaryto
HeliosExited 2022
ConstructionFrance· Entry 2019
Trade Saleto
IndustrialsFrance· Entry 2019
Secondaryto
Marcel & FilsExited 2021
ConsumerFrance· Entry 2015
Secondaryto
Meotec
MeotecExited 2024
TMTFrance· Entry 2018
Secondaryto
Novepan
NovepanExited 2022
ConsumerFrance· Entry 2017
Secondaryto
HealthcareFrance· Entry 2019
Trade Saleto
Business ServicesFrance· Entry 2020
Secondaryto
Vivalto Vie
Vivalto VieExited 2020
HealthcareFrance· Entry 2015
Secondaryto
Azulis MMF IVBuyoutDivesting
2011 · 15yr€225M0 active · 8 realized

Realized

8 exits
BioclinicExited 2018
HealthcareFrance· Entry 2012
Secondaryto
CEME
CEMEExited 2022
ConstructionFrance· Entry 2014
Secondaryto
Father & Sons
Father & SonsExited 2025
ConsumerFrance· Entry 2014
MBOto
Holweg WeberExited 2018
IndustrialsFrance· Entry 2012
Secondaryto
Ital Express
Ital ExpressExited 2019
LogisticsFrance· Entry 2014
Secondaryto
Lagarrigue
LagarrigueExited 2016
MedTechFrance· Entry 2011
Secondaryto
LV OverseasExited 2019
LogisticsFrance· Entry 2013
Secondaryto
SitourExited 2017
Business ServicesFrance· Entry 2011
Secondaryto
Azulis MMF IIIBuyoutRealized
2004 · 22yr€109M0 active · 8 realized

Realized

8 exits
IndustrialsFrance· Entry 2010
Secondaryto
IniceaExited 2016
HealthcareFrance· Entry 2010
Secondaryto
ConsumerFrance· Entry 2009
Secondaryto
Martine SpecialitesExited 2013
ConsumerFrance· Entry 2009
Secondaryto
Optimum
OptimumExited 2015
ConstructionFrance· Entry 2010
Secondaryto
Prodene KlintExited 2014
ConsumerFrance· Entry 2009
Trade Saleto
IndustrialsFrance· Entry 2009
MBOto
SavenaExited 2011
ConsumerFrance· Entry 2007
Secondaryto
Track Azulis Capital

Saved GPs appear in your watchlist, one click from your workspace.

About Azulis Capital

Azulis Capital is a French mid-market private equity firm with €495 million of assets under management as of December 2024, headquartered in Paris. The firm has built a multi-decade track record across successive flagship vintage funds focused on French mid-cap LBO transactions, with sector breadth across industrials, healthcare, business services and consumer verticals spanning the French mid-market spectrum.

Investment thesis

Azulis targets French mid-cap LBO transactions with equity ticket sizes typically ranging from €10 million to €40 million per transaction, focusing on profitable companies with strong management teams and growth potential. Sector focus spans Industrials, Healthcare, TMT and Business Services, with the firm emphasising operational value creation through management team partnership and selective bolt-on M&A strategies across the holding period.

Recent activity

Recent realised exits include Ital Express (industrials, 2024), Meotec (TMT, 2024), Radiologie Paris Ouest (healthcare, 2024) and CEME (industrials, 2022), reflecting active distribution across multiple sectors. The platform tracks 4 funds, 18 active portfolio companies and 22 realised exits across the multi-vintage French mid-cap programme. Detailed buyer names and multiple data available on Pro at €29/month.

Get the full picture on Azulis Capital.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Save this GP to your watchlist
Saved searches that re-run your sourcing filters in one click
Geography breakdown across 1 geography
Exit buyers and MOIC on every realized deal (Pro)
Export, compare GPs side by side (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Last updated August 2026 · Sourced from public filings · Report an issue